October 3, 2022
The National Cancer Institute has awarded the UNC Lineberger Pancreatic Cancer Center of Excellence a five-year, $10.9 million Pancreatic Cancer Specialized Program of Research Excellence (SPORE) grant.
August 26, 2022
UNC Lineberger’s Channing Der, PhD, and Kirsten Bryant, PhD, are among seven recipients of the inaugural Pancreatic Cancer Action Network (PanCAN) Therapeutic Accelerator Collaborative Award, which provides a total of $340,000 in grant support over two years.
June 20, 2022
UNC Lineberger hosted a symposium for postdoctoral fellows to hear from three scientists who have chosen different science career paths after earning their doctoral degree.
May 6, 2022
UNC Lineberger’s 45th annual Scientific Symposium featured talks on the latest research on pancreatic cancer, tumor microenvironments, metastatic disease and immunotherapy.
April 16, 2021
The Pancreatic Cancer Center of Excellence brings together researchers, clinicians and staff to provide excellent multidisciplinary patient care and generate research discoveries that can be translated into new, more effective approaches for pancreatic cancer.
November 9, 2020
Pancreatic cancer is an extremely challenging cancer to treat and has an increasing incidence in the United States. Fortunately, pancreatic cancer research is being conducted at UNC Lineberger.
November 26, 2019
The honor recognizes Der's contributions to cancer research. His lab's recent findings on pancreatic cancer have led to clinical studies of a new treatment.
November 18, 2019
The KRAS gene is commonly mutated in cancer. In the journal Cancer Discovery, researchers led by Channing Der, PhD, and Aaron Hobbs, PhD, reported details of the role of the KRAS G12R mutation in pancreatic cancer, and therapeutic strategies that might work for this mutation type. By studying unique differences in DNA mutations within the same gene, researchers are working to uncover the mutation-specific mechanisms that drive cancerous growth.
March 4, 2019
Scientists at UNC Lineberger discovered a technique to make pancreatic cancer cells reliant on one energy source and then starve them of it, which has led to clinical studies of a novel treatment strategy.
April 13, 2018
UNC Lineberger researchers led by Channing Der, PhD, are reporting preclinical findings for a potential two-treatment strategy to block multiple mechanisms of cancer cell metabolism in pancreatic cancer at the American Association for Cancer Research Annual Meeting in Chicago.
